U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C5H13FNO
Molecular Weight 122.1612
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 1

SHOW SMILES / InChI
Structure of FLUOROCHOLINE

SMILES

C[N+](C)(CF)CCO

InChI

InChIKey=PBVFROWIWWGIFK-UHFFFAOYSA-N
InChI=1S/C5H13FNO/c1-7(2,5-6)3-4-8/h8H,3-5H2,1-2H3/q+1

HIDE SMILES / InChI

Molecular Formula C5H12FNO
Molecular Weight 121.1533
Charge 0
Count
Stereochemistry RACEMIC
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Description
Curator's Comment: The description was created based on several sources, including https://www.ncbi.nlm.nih.gov/pubmed/28409220 | https://clinicaltrials.gov/ct2/show/NCT03105869 | https://www.ncbi.nlm.nih.gov/pubmed/29145267 | https://www.ncbi.nlm.nih.gov/pubmed/25063039

Fluorocholine is (18F-fluorocholine) is a specific promising agent for imaging tumor cell proliferation, particularly in prostate cancer, using PET/CT. Fluorocholine is a beneficial tool in the early detection of marrow-based metastases because it excludes distant metastases and evaluates the response to hormone therapy. In addition, 18F-fluorocholine has the potential to differentiate between degenerative and malignant osseous abnormalities because degenerative changes are not choline-avid.

Approval Year

Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Diagnostic
Unknown

Approved Use

Unknown
Diagnostic
Unknown

Approved Use

Unknown
Diagnostic
Unknown

Approved Use

Unknown
PubMed

PubMed

TitleDatePubMed
Erratum to: Dual Pathologies of Parathyroid Adenoma and Papillary Thyroid Cancer on Fluorocholine and Fluorodeoxyglucose PET/CT.
2018 Feb
Patents

Sample Use Guides

Patients were injected with 100 MBq of 18F-fluorocholine
Route of Administration: Intravenous
The incorporation of [18F]FDG and [18F]FCH (Fluorocholine) was determined through the uptake of the radiotracer into the trichloroacetic acid-insoluble cellular fraction of tumor cell lines. Briefly, cells were seeded in 96-well plates at 10,000 cells per well. After 30 min of incubation with 500 μCi/ml of [18F]FDG or [18F]FCH, cells were washed twice in icecold PBS and precipitated with ice-cold 5% trichloroacetic acid. Then, cells were washed once with ice-cold 95% ethanol and solubilized with 1N NaOH. An aliquot was neutralized, and the radioactivity was determined in a liquid scintillation counter. All experiments were performed in triplicate. A measurable uptake of [18F]FCH and [18F]FDG was observed in the five tumor cell lines. The incorporation of both tracers increased from 10 to 60 min.
Substance Class Chemical
Created
by admin
on Sat Dec 16 10:45:48 GMT 2023
Edited
by admin
on Sat Dec 16 10:45:48 GMT 2023
Record UNII
6029HGL0QP
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
FLUOROCHOLINE
Systematic Name English
FLUOROMETHYLDIMETHYL-2-HYDROXYETHYL-AMMONIUM
Systematic Name English
FLUOROMETHYLCHOLINE
Systematic Name English
FCH
Common Name English
ETHANAMINIUM, N-(FLUOROMETHYL)-2-HYDROXY-N,N-DIMETHYL-
Systematic Name English
Code System Code Type Description
PUBCHEM
404592
Created by admin on Sat Dec 16 10:45:48 GMT 2023 , Edited by admin on Sat Dec 16 10:45:48 GMT 2023
PRIMARY
EPA CompTox
DTXSID60328055
Created by admin on Sat Dec 16 10:45:48 GMT 2023 , Edited by admin on Sat Dec 16 10:45:48 GMT 2023
PRIMARY
FDA UNII
6029HGL0QP
Created by admin on Sat Dec 16 10:45:48 GMT 2023 , Edited by admin on Sat Dec 16 10:45:48 GMT 2023
PRIMARY
CAS
791056-61-6
Created by admin on Sat Dec 16 10:45:48 GMT 2023 , Edited by admin on Sat Dec 16 10:45:48 GMT 2023
PRIMARY
WIKIPEDIA
Fluorocholine
Created by admin on Sat Dec 16 10:45:48 GMT 2023 , Edited by admin on Sat Dec 16 10:45:48 GMT 2023
PRIMARY